T1	Disease	69 97	EGFR -mutated NSCLC patients
T2	Gene_or_protein	118 127	EGFR -TKI
T3	Chemical	118 132	EGFR -TKI used
T4	Chemical	322 333	itinib rech
T5	Disease	350 372	mutated NSCLC patients
T6	Chemical	410 466	I followed by a subsequent line of treatment ( excluding
T7	Chemical	475 481	Is ) .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	treats	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T1	Arg2:T6
R6	isAssociatedWith	Arg1:T1	Arg2:T7
R7	treats	Arg1:T2	Arg2:T1
R8	influences	Arg1:T2	Arg2:T3
R9	influences	Arg1:T2	Arg2:T4
R10	treats	Arg1:T2	Arg2:T5
R11	treats	Arg1:T2	Arg2:T6
R12	treats	Arg1:T2	Arg2:T7
R13	treats	Arg1:T3	Arg2:T1
R14	influences	Arg1:T3	Arg2:T2
R15	influences	Arg1:T3	Arg2:T4
R16	treats	Arg1:T3	Arg2:T5
R17	treats	Arg1:T3	Arg2:T6
R18	treats	Arg1:T3	Arg2:T7
R19	treats	Arg1:T4	Arg2:T1
R20	influences	Arg1:T4	Arg2:T2
R21	influences	Arg1:T4	Arg2:T3
R22	treats	Arg1:T4	Arg2:T5
R23	influences	Arg1:T4	Arg2:T6
R24	influences	Arg1:T4	Arg2:T7
R25	treats	Arg1:T5	Arg2:T1
R26	isAssociatedWith	Arg1:T5	Arg2:T2
R27	isAssociatedWith	Arg1:T5	Arg2:T3
R28	isAssociatedWith	Arg1:T5	Arg2:T4
R29	isAssociatedWith	Arg1:T5	Arg2:T6
R30	isAssociatedWith	Arg1:T5	Arg2:T7
R31	treats	Arg1:T6	Arg2:T1
R32	influences	Arg1:T6	Arg2:T2
R33	influences	Arg1:T6	Arg2:T3
R34	influences	Arg1:T6	Arg2:T4
R35	treats	Arg1:T6	Arg2:T5
R36	treats	Arg1:T6	Arg2:T7
R37	treats	Arg1:T7	Arg2:T1
R38	influences	Arg1:T7	Arg2:T2
R39	influences	Arg1:T7	Arg2:T3
R40	influences	Arg1:T7	Arg2:T4
R41	treats	Arg1:T7	Arg2:T5
R42	influences	Arg1:T7	Arg2:T6
